Ebola Virus Net is the web resource for anyone interested in ebola. Ebola (Ebola hemorrhagic fever), is a severe, often fatal disease in humans and nonhuman primates such as monkeys, gorillas, and chimpanzees. Ebola is a rare and deadly disease caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There are five identified Ebolavirus species, four of which have caused disease in humans. Ebola is found in several African countries. The first Ebola species was discovered in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. The largest outbreak to date was the epidemic in West Africa, which occurred from December 2013, to January 2016, with 28,646 cases and 11,323 deaths. Other outbreaks in Africa began in the Democratic Republic of the Congo in May 2017 and 2018. In July 2019, the World Health Organization declared the Congo Ebola outbreak a world health emergency.

When an infection does occur in humans, the virus can be spread to others through direct contact with the blood or body fluids of a person who is sick with Ebola, or through contact with objects that have been contaminated with the blood or body fluids of an infected person. Until recent, no vaccines were effective. In December 2016, Ebola was found to be 70–100% prevented by rVSV-ZEBOV vaccine, making it the first proven vaccine against the disease. More than 100,000 people have been vaccinated against Ebola as of 2019.

The objectives of Ebola Virus Net are to be the public and professional information resource for ebola and to serve as a network in the exchange of information and news related to ebola.

• Marburg virus: Eight new cases of 'highly virulent, Ebola like' disease found in Equatorial Guinea - Sky News
  Thu, 23 Mar 2023 14:59 GMT
• '12 Dead': Marburg Virus Raises Alarm in Africa, What is this Disease 'Almost as Deadly as Ebola'? - News18
  Sun, 26 Mar 2023 11:05 GMT
• Marburg Virus Outbreak: Tanzania Announces Spread of Deadly Disease - Newsweek
  Thu, 23 Mar 2023 16:43 GMT
• Risk Ebola-like Marburg virus will ‘spread internationally’, scientists warn – as up to 32 dead... - The Irish Sun
  Fri, 24 Mar 2023 10:48 GMT
• What is the killer Marburg virus and how worried should we be - TRT World
  Fri, 24 Mar 2023 11:05 GMT
• Ebola-like Marburg virus kills five people in Tanzania - BBC
  Wed, 22 Mar 2023 14:27 GMT
• Unidentified Illness Kills Five in Tanzania, Sparks Ebola Fears - Voice of America - VOA News
  Fri, 17 Mar 2023 07:00 GMT
• Tanzania: Anticipatory Actions for Ebola Outbreak, Operational ... - ReliefWeb
  Thu, 23 Mar 2023 13:45 GMT
• Guinea's Ebola orphans feel abandoned - dw.com
  Tue, 21 Mar 2023 13:05 GMT
• WHO calls in experts to decide on conflicting Ebola sex abuse reports - The New Humanitarian
  Wed, 01 Mar 2023 08:00 GMT
• EXCLUSIVE: More women accuse aid workers in Ebola sex abuse ... - The New Humanitarian
  Wed, 08 Mar 2023 08:00 GMT
• End of Ebola Outbreak in Uganda: WHO, Ministry of Health Conduct ... - WHO | Regional Office for Africa
  Thu, 16 Feb 2023 08:00 GMT
• Russia claims US biologists may be behind Ebola virus spread in Central Africa in 2022 - Republic World
  Fri, 10 Mar 2023 08:00 GMT
• What is the Marburg virus? Another country reports outbreak of ‘highly virulent’ disease - KTLA Los Angeles
  Sat, 25 Mar 2023 18:00 GMT
• Teamwork Key to Success for Army Lab's 2022 Employee of the Year - DVIDS
  Fri, 24 Mar 2023 19:19 GMT

• PRO/AH/EDR> Ebola update (44): Burkina Faso ex Cote d'Ivoire, 2nd case, NOT
  Mon, 30 Aug 2021 11:01:25 -0400
  Ebola -- Burkina Faso
  On 22 Aug 2021, the Ministry of Health informed the population of the admission to the Medical Emergencies of the Bogodogo University Hospital (CHU-B) of a 22-year-old patient who had stayed in the Republic of [Cote d'Ivoire]. The diagnostic procedure consisted of sampling analysis at the National Reference Laboratory for Viral Haemorrhagic Fever (LNR-FHV at the Muraz Centre) and the Pasteur Institute of Dakar for confirmation. The results obtained make it possible to permanently rule out

• Modelling the impact of stigmatisation of Ebola survivors on the disease transmission dynamics Sat, 25 Mar 2023 06:00:00 -0400
  Ebola virus disease (EVD) is one of the most highly stigmatised diseases in any affected country because of the disease's high infectivity and case fatality rate. Infected individuals and most especially survivors are often stigmatised by their communities for fear of contagion. We propose and analyse a mathematical model to examine the impact of stigmatisation of Ebola survivors on the disease dynamics. The model captures both the internal stigmatisation experienced by infected individuals...
• On the importance and challenges of global access to proven life-saving treatments for Ebolavirus - Authors' reply Fri, 24 Mar 2023 06:00:00 -0400
  No abstract
• On the importance and challenges of global access to proven life-saving treatments for Ebolavirus Fri, 24 Mar 2023 06:00:00 -0400
  No abstract
• Qualitative assessment of hand hygiene knowledge, attitudes and practices among healthcare workers prior to the implementation of the WHO Hand Hygiene Improvement Strategy at Faranah Regional Hospital, Guinea Fri, 24 Mar 2023 06:00:00 -0400
  Healthcare-associated infections are a serious burden globally. Few qualitative studies have explored healthcare workers' knowledge, attitudes and practices of hand hygiene. Prior to the implementation of the World Health Organization's Hand Hygiene Improvement Strategy at Faranah Regional Hospital in the Upper Region of Guinea in December 2018, we conducted a qualitative baseline assessment of knowledge, attitudes and practices of hand hygiene among healthcare workers to guide future hand...
• Factors affecting trust in clinical trials conduct: Views of stakeholders from a qualitative study in Ghana Fri, 24 Mar 2023 06:00:00 -0400
  Evidence exists that scientists' dehumanization and exploitation of people in the name of science led to suspicion and mistrust in clinical trials conduct. In Ghana, there are equally signs of public distrust in the conduct of biomedical research. Typical examples are the unsuccessful conduct of the Ebola vaccine trial and the initial refusal of parents to allow their children to receive the recently piloted malaria vaccine in Ghana. Therefore, this study explored participants' views on factors...
• Aid when 'there is nothing left to offer': Experiences of palliative care and palliative care needs in humanitarian crises Fri, 24 Mar 2023 06:00:00 -0400
  Access to palliative care, and more specifically the alleviation of avoidable physical and psychosocial suffering is increasingly recognized as a necessary component of humanitarian response. Palliative approaches to care can meet the needs of patients for whom curative treatment may not be the aim, not just at the very end of life but alleviation of suffering more broadly. In the past several years many organizations and sectoral initiatives have taken steps to develop guidance and policies to...
• The World Health Organization's Disease Outbreak News: A retrospective database Fri, 24 Mar 2023 06:00:00 -0400
  The World Health Organization (WHO) notifies the global community about disease outbreaks through the Disease Outbreak News (DON). These online reports tell important stories about both outbreaks themselves and the high-level decision making that governs information sharing during public health emergencies. However, they have been used only minimally in global health scholarship to date. Here, we collate all 2,789 of these reports from their first use through the start of the Covid-19 pandemic...
• The impact of sampling bias on viral phylogeographic reconstruction Fri, 24 Mar 2023 06:00:00 -0400
  Genomic epidemiology plays an ever-increasing role in our understanding of and response to the spread of infectious pathogens. Phylogeography, the reconstruction of the historical location and movement of pathogens from the evolutionary relationships among sampled pathogen sequences, can inform policy decisions related to viral movement among jurisdictions. However, phylogeographic reconstruction is impacted by the fact that the sampling and virus sequencing policies differ among jurisdictions,...
• Assessing routine health information system performance during the tenth outbreak of Ebola virus disease (2018-2020) in the Democratic Republic of the Congo: A qualitative study in North Kivu Fri, 24 Mar 2023 06:00:00 -0400
  The Democratic Republic of Congo has implemented reforms to its national routine health information system (RHIS) to improve timeliness, completeness, and use of quality data. However, outbreaks can undermine efforts to strengthen it. We assessed the functioning of the RHIS during the 2018-2020 outbreak of Ebola Virus Disease (EVD) to identify opportunities for future development. We conducted a qualitative study in North Kivu, from March to May 2020. Semi-structured interviews were conducted...
• Are socio-demographic and economic characteristics good predictors of misinformation during an epidemic? Fri, 24 Mar 2023 06:00:00 -0400
  We combine data on beliefs about the origin of the 2014 Ebola outbreak with two supervised machine learning methods to predict who is more likely to be misinformed. Contrary to popular beliefs, we uncover that, socio-demographic and economic indicators play a minor role in predicting those who are misinformed: misinformed individuals are not any poorer, older, less educated, more economically distressed, more rural, or ethnically different than individuals who are informed. However, they are...